GB9019703D0 - Antibodies for use in antilymphocyte antibody therapy - Google Patents

Antibodies for use in antilymphocyte antibody therapy

Info

Publication number
GB9019703D0
GB9019703D0 GB909019703A GB9019703A GB9019703D0 GB 9019703 D0 GB9019703 D0 GB 9019703D0 GB 909019703 A GB909019703 A GB 909019703A GB 9019703 A GB9019703 A GB 9019703A GB 9019703 D0 GB9019703 D0 GB 9019703D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
antibody therapy
antilymphocyte antibody
antilymphocyte
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB909019703A
Other versions
GB2233559B (en
GB2233559A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888805792A external-priority patent/GB8805792D0/en
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Priority to GB9019703A priority Critical patent/GB2233559B/en
Publication of GB9019703D0 publication Critical patent/GB9019703D0/en
Publication of GB2233559A publication Critical patent/GB2233559A/en
Application granted granted Critical
Publication of GB2233559B publication Critical patent/GB2233559B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9019703A 1988-03-11 1989-03-13 Antibodies for use in antilymphocyte antibody therapy Expired - Lifetime GB2233559B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9019703A GB2233559B (en) 1988-03-11 1989-03-13 Antibodies for use in antilymphocyte antibody therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888805792A GB8805792D0 (en) 1988-03-11 1988-03-11 Medicaments
GB9019703A GB2233559B (en) 1988-03-11 1989-03-13 Antibodies for use in antilymphocyte antibody therapy
PCT/GB1989/000254 WO1989008460A1 (en) 1988-03-11 1989-03-13 Antibodies for use in antilymphocyte antibody therapy

Publications (3)

Publication Number Publication Date
GB9019703D0 true GB9019703D0 (en) 1990-10-24
GB2233559A GB2233559A (en) 1991-01-16
GB2233559B GB2233559B (en) 1992-03-04

Family

ID=26293617

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9019703A Expired - Lifetime GB2233559B (en) 1988-03-11 1989-03-13 Antibodies for use in antilymphocyte antibody therapy

Country Status (1)

Country Link
GB (1) GB2233559B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870163A (en) * 1985-08-29 1989-09-26 New York Blood Center, Inc. Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
DE3631229A1 (en) * 1986-09-13 1988-03-24 Basf Ag MONOCLONAL ANTIBODIES AGAINST HUMAN TUMORNESCROSE FACTOR (TNF) AND THEIR USE

Also Published As

Publication number Publication date
GB2233559B (en) 1992-03-04
GB2233559A (en) 1991-01-16

Similar Documents

Publication Publication Date Title
IL89489A0 (en) Chimeric antibodies directed against human carcinoembryonic antigen
IL93840A0 (en) Novel monoclonal antibody to novel antigen associated with human tumors
HUT66753A (en) Novel antibodies and methods for their use
HU9400201D0 (en) Recombinant antibodies for human therapy
HUT53126A (en) Antibody medicament conjugates
EP0240344A3 (en) Monoclonal antibodies and their use
IL90017A0 (en) Monoclonal antibodies
ZA898777B (en) Monoclonal antibodies
EP0285511A3 (en) Monoclonal antibodies and their uses
IL92232A0 (en) Anti-fucosylceramide monoclonal antibody
EP0257421A3 (en) Antibodies for use in determining human glycoalbumin
GB2233559B (en) Antibodies for use in antilymphocyte antibody therapy
ZA89258B (en) Monoclonal antibodies
GB8820036D0 (en) Monoclonal antibodies
EP0407586A4 (en) Human monoclonal antibody and process for its preparation
GB8901832D0 (en) Human monoclonal antibody and its production and use
GB8830115D0 (en) Monoclonal antibody and preparation and use thereof
AU5217890A (en) Monoclonal antibodies in vaccine formulations
EP0252768A3 (en) Anti-lafora body monoclonal antibody
EP0423333A4 (en) Anti-endoserine antibody
GB8812137D0 (en) Antibodies
ZA876206B (en) Antibodies for use in determining human glycoalbumin
EP0336441A3 (en) Anti-cpbii monoclonal antibody
GB8816272D0 (en) Antibody & antigen
IE891095L (en) Human monoclonal antibodies

Legal Events

Date Code Title Description
773K Patent revoked under sect. 73(2)/1977